相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
Ralf Gold et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
Ralf Gold et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
E. Havrdova et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
No evident disease activity: The use of combined assessments in the management of patients with multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Treatment decisions in multiple sclerosis - insights from real-world observational studies
Maria Trojano et al.
NATURE REVIEWS NEUROLOGY (2017)
No evident disease activity: The use of combined assessments in the management of patients with multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
Raed Alroughani et al.
NEUROLOGY AND THERAPY (2017)
Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM
Oscar Fernandez et al.
CLINICAL THERAPEUTICS (2017)
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study
A. Miclea et al.
JOURNAL OF NEUROLOGY (2016)
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations
P. Gallo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study
J. Theodore Phillips et al.
NEUROLOGY AND THERAPY (2015)
Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel
J. Theodore Phillips et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
分享论文
